138 related articles for article (PubMed ID: 3532418)
61. Immunopurification and characterization of a collagenase/gelatinase domain issued from basement membrane fibronectin.
Boudjennah L; Dalet-Fumeron V; Ylätupa S; Pagano M
FEBS Lett; 1996 Aug; 391(1-2):52-6. PubMed ID: 8706929
[TBL] [Abstract][Full Text] [Related]
62. Rapid methods for isolation of human plasma fibronectin.
Miekka SI; Ingham KC; Menache D
Thromb Res; 1982 Jul; 27(1):1-14. PubMed ID: 6812233
[TBL] [Abstract][Full Text] [Related]
63. Enhancement of heparin-binding ability of fibronectin by S-carboxamide-methylation.
Kohama Y; Miyamoto T; Oka H; Yamamoto K; Murayama N; Tsujikawa K; Okabe M; Mimura T
J Pharmacobiodyn; 1989 Oct; 12(10):626-33. PubMed ID: 2630632
[TBL] [Abstract][Full Text] [Related]
64. Fluid-phase interaction between human plasma fibronectin and gelatin determined by fluorescence polarization assay.
Forastieri H; Ingham KC
Arch Biochem Biophys; 1983 Dec; 227(2):358-66. PubMed ID: 6364982
[TBL] [Abstract][Full Text] [Related]
65. Transformation-enhancing activity of gelatin-binding fragments of fibronectin.
De Petro G; Barlati S; Vartio T; Vaheri A
Proc Natl Acad Sci U S A; 1981 Aug; 78(8):4965-9. PubMed ID: 6458038
[TBL] [Abstract][Full Text] [Related]
66. Model of fibronectin tertiary structure based on studies of interactions between fragments.
Homandberg GA; Erickson JW
Biochemistry; 1986 Nov; 25(22):6917-25. PubMed ID: 3801402
[TBL] [Abstract][Full Text] [Related]
67. Fibronectin purification from human plasma in a packed-bed column system with gelatin immobilized PHEMA microspheres.
Kayirhan-Denizli F; Arica MY; Denizli A
J Biomater Sci Polym Ed; 2001; 12(5):479-89. PubMed ID: 11469779
[TBL] [Abstract][Full Text] [Related]
68. Interaction of plasma fibronectin with gelatin and complement C1q.
Ingham KC; Brew SA; Miekka SI
Mol Immunol; 1983 Mar; 20(3):287-95. PubMed ID: 6602941
[TBL] [Abstract][Full Text] [Related]
69. Isolation and characterization of rat plasma fibronectin.
Weiss RE; Reddi AH
Biochem J; 1981 Sep; 197(3):529-34. PubMed ID: 7034721
[TBL] [Abstract][Full Text] [Related]
70. Localization and chemical synthesis of fibronectin peptides with melanoma adhesion and heparin binding activities.
McCarthy JB; Chelberg MK; Mickelson DJ; Furcht LT
Biochemistry; 1988 Feb; 27(4):1380-8. PubMed ID: 2966638
[TBL] [Abstract][Full Text] [Related]
71. Monoclonal antibody against the N-terminal end of human plasma fibronectin.
Vartio T; Salonen EM; De Petro G; Barlati S; Miggiano V; Stähli C; Virgallita G; Takács B; Vaheri A
Biochem J; 1983 Oct; 215(1):147-51. PubMed ID: 6194791
[TBL] [Abstract][Full Text] [Related]
72. Location of heparin-binding sites of fibronectin. Detection of a hitherto unrecognized transamidase sensitive site.
Richter H; Seidl M; Hörmann H
Hoppe Seylers Z Physiol Chem; 1981 Apr; 362(4):399-408. PubMed ID: 7239439
[TBL] [Abstract][Full Text] [Related]
73. [Optimization of the purification of human plasma fibronectin by double affinity chromatography using gelatin and heparin Trisacryl LS].
Allary M; Amoignon T; Lafargue O; Sene C; Boschetti E; Saint-Blancard J
Rev Fr Transfus Hemobiol; 1989 Apr; 32(2):107-13. PubMed ID: 2757725
[TBL] [Abstract][Full Text] [Related]
74. Affinity chromatography of collagen on collagen-binding fragments of fibronectin.
Engvall E; Bell ML; Ruoslahti E
Coll Relat Res; 1981 Nov; 1(6):505-16. PubMed ID: 7346232
[TBL] [Abstract][Full Text] [Related]
75. Location of a gelatin-binding region of human plasma fibronectin.
Furie MB; Frey AB; Rifkin DB
J Biol Chem; 1980 May; 255(10):4391-4. PubMed ID: 7372581
[No Abstract] [Full Text] [Related]
76. A fibronectin self-assembly site involved in fibronectin matrix assembly: reconstruction in a synthetic peptide.
Morla A; Ruoslahti E
J Cell Biol; 1992 Jul; 118(2):421-9. PubMed ID: 1629240
[TBL] [Abstract][Full Text] [Related]
77. Biochemical characterization of the fibronectin binding sites for IgG.
Rostagno AA; Frangione B; Gold LI
J Immunol; 1989 Nov; 143(10):3277-82. PubMed ID: 2553808
[TBL] [Abstract][Full Text] [Related]
78. Latent fibronectin-degrading serine proteinase activity in N-terminal heparin-binding domain of human plasma fibronectin.
Lambert Vidmar S; Lottspeich F; Emod I; Planchenault T; Keil-Dlouha V
Eur J Biochem; 1991 Oct; 201(1):71-7. PubMed ID: 1915379
[TBL] [Abstract][Full Text] [Related]
79. Demonstration of structural differences between the two subunits of human-plasma fibronectin in the carboxy-terminal heparin-binding domain.
Pande H; Calaycay J; Lee TD; Legesse K; Shively JE; Siri A; Borsi L; Zardi L
Eur J Biochem; 1987 Jan; 162(2):403-11. PubMed ID: 3803394
[TBL] [Abstract][Full Text] [Related]
80. Gelatin-binding domain-specific anti-human plasma fibronectin Fab' inhibits fibronectin-mediated gelatin binding but not cell spreading.
McDonald JA; Broekelmann TJ; Kelley DG; Villiger B
J Biol Chem; 1981 Jun; 256(11):5583-7. PubMed ID: 7240156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
